Cochlear to acquire Oticon Medical from Demant for $121m.

Cochlear, an implantable hearing solutions provider, agreed to acquire Oticon Medical, a medical company, from Demant, a company that provides hearing healthcare solutions, for $121m. "We look forward to welcoming Oticon Medical's implant customers to the Cochlear family. Driven by our mission to innovate and deliver a lifetime of hearing outcomes, we will seek to ensure that Oticon Medical's customers continue to be supported with a lifetime of hearing solutions. We will work closely with Demant to ensure a seamless transition, with continued access to current Oticon Medical technology for customers in the coming years. We will develop next generation sound processors and services that will enable customers to transition to and benefit from Cochlear's technology platform over time," Dig Howitt, Cochlear CEO & President.